R&D Why are eCOA studies still so challenging? Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
R&D Bridging ethics and efficacy in IRB review of vaccine trials Institutional Review Boards (IRBs) play a key role in evaluating scientific integrity and participant safety.
Digital AI is reshaping drug discovery - Now it must prove it can be... As innovation pushes the boundaries of speed and scale, a question remains: can we use transparency as a way to prove safety and build public trust?
Patients Streamlining post-trial treatment access for rare disease pa... Companies have a practical and ethical responsibility to continue treating patients when clinical trial data collection ends mid-trial.
News Controversial project aims to make artificial human genomes A landmark project funded by Wellcome aims to develop the tools needed to synthesise human genomes – and simultaneously probe the social implications.
Sales & Marketing Sponsored 12 Questions with Jackie Marchington Jackie Marchington is Head of Compliance and Ethics for IPG Health Medical Communications.
News TransThera's resistant biliary cancer drug cleared in China TransThera's Yochanra has been cleared in China as the world's first drug that can overcome resistance to FGFR inhibitors in cholangiocarcinoma.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
